Susquehanna International Group’s GeneDx Holdings Warrant WGSWW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-79,691
Closed -$3.78K 14222
2025
Q4
$3.78K Buy
+79,691
New +$5.56K ﹤0.01% 12106
2025
Q2
Sell
-28,177
Closed -$5.92K 13820
2025
Q1
$5.92K Buy
+28,177
New +$6.31K ﹤0.01% 12250
2023
Q4
Sell
-11,433
Closed -$342 13405
2023
Q3
$342 Buy
+11,433
New +$318 ﹤0.01% 11907
2022
Q1
Sell
-12,114
Closed -$12K 14086
2021
Q4
$12K Buy
+12,114
New +$23.8K ﹤0.01% 12913

Other funds holding WGSWW

Susquehanna International Group's WGSWW Position: Q1 2026 in Review

Susquehanna International Group sold out of GeneDx Holdings Warrant (WGSWW) in Q1 2026, closing a stake of 79,691 shares — an estimated $3.78K sold.

Susquehanna International Group first reported a position in WGSWW in Q4 2021 and held it in 4 quarters. The position peaked at $12K in Q4 2021. 13 funds tracked by Wall St. Rank hold WGSWW as of Q1 2026.

  • Susquehanna International Group reported no remaining GeneDx Holdings Warrant position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 79,691 GeneDx Holdings Warrant shares in Q1 2026, an estimated $3.78K.
  • Susquehanna International Group first reported a position in GeneDx Holdings Warrant in Q4 2021 and held it in 4 quarters.
  • Susquehanna International Group's GeneDx Holdings Warrant position peaked at $12K in Q4 2021.
  • 13 funds tracked by Wall St. Rank held GeneDx Holdings Warrant as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.